Latest news with #PBHealthcare


Economic Times
2 days ago
- Business
- Economic Times
VC investments in India at $3.5-bn mark in Q2, 2025: KPMG
Venture Capital (VC) investments in India touched USD 3.5 billion across 355 deals in Q2 of 2025, warming up sequentially in value terms from USD 2.8 billion across 456 deals in March quarter, according to a latest KPMG report. Fintech remained one of the hottest sectors for investment in India, KPMG Venture Pulse Q2 2025 report said. "India's venture capital landscape demonstrated resilience in Q2, 2025, with funding rising despite global uncertainties. Key sectors like fintech, healthtech, and logistics drew strong investor interest, reflecting confidence in India's innovation potential," said Nitish Poddar, Partner and National Leader, Private Equity, KPMG in India. The performance underscores the country's growing role in shaping the region's startup ecosystem, Poddar added. A USD 218 million seed round raise by PB Healthcare -- a startup focused on developing a tech-enabled health delivery platform was India's largest VC investment of Q2, 2025. "VC investment in India rose from USD 2.8 billion across 456 deals to USD 3.5 billion across 355 deals quarter-over-quarter," it said. On a broader canvas, the global venture capital investment slipped to USD 101.05 billion in Q2, 2025 from USD 128.4 billion in Q1, 2025. The drop notwithstanding, "Q2'25 remained a relatively strong quarter despite ongoing geopolitical conflicts, trade tensions, and macroeconomic uncertainty", as per the report. The focus remained primarily on large-scale opportunities, especially in the AI and defencetech space, it further said. Heading into Q3'25, VC investors globally are expected to remain cautious given the continued delay in exits across many sectors, rising geopolitical tensions, and ongoing uncertainties related to tariffs and other global trade policies. "AI will likely remain the hottest sector of VC investment globally -- particularly as governments continue to introduce large-scale funding programs to attract AI startups and drive ecosystem development and technology sovereignty," according to KPMG.


Time of India
2 days ago
- Business
- Time of India
VC investments in India at $3.5-billion mark in Q2, 2025: KPMG
Academy Empower your mind, elevate your skills Venture Capital (VC) investments in India touched $3.5 billion across 355 deals in Q2 of 2025, warming up sequentially in value terms from $2.8 billion across 456 deals in March quarter, according to a latest KPMG remained one of the hottest sectors for investment in India, KPMG Venture Pulse Q2 2025 report said."India's venture capital landscape demonstrated resilience in Q2, 2025, with funding rising despite global uncertainties. Key sectors like fintech, healthtech, and logistics drew strong investor interest, reflecting confidence in India's innovation potential," said Nitish Poddar, Partner and National Leader, Private Equity, KPMG in performance underscores the country's growing role in shaping the region's startup ecosystem, Poddar added.A USD 218 million seed round raise by PB Healthcare -- a startup focused on developing a tech-enabled health delivery platform was India's largest VC investment of Q2, 2025."VC investment in India rose from USD 2.8 billion across 456 deals to USD 3.5 billion across 355 deals quarter-over-quarter," it a broader canvas, the global venture capital investment slipped to USD 101.05 billion in Q2, 2025 from USD 128.4 billion in Q1, drop notwithstanding, "Q2'25 remained a relatively strong quarter despite ongoing geopolitical conflicts, trade tensions, and macroeconomic uncertainty", as per the focus remained primarily on large-scale opportunities, especially in the AI and defencetech space, it further into Q3'25, VC investors globally are expected to remain cautious given the continued delay in exits across many sectors, rising geopolitical tensions, and ongoing uncertainties related to tariffs and other global trade policies."AI will likely remain the hottest sector of VC investment globally -- particularly as governments continue to introduce large-scale funding programs to attract AI startups and drive ecosystem development and technology sovereignty," according to KPMG.


Mint
08-05-2025
- Business
- Mint
PB Healthcare secures $218 million in seed funding from PB Fintech, General Catalyst
PB Healthcare Services Pvt. Ltd has secured seed funding of $218 million from global investment firm General Catalyst, PB Fintech Ltd and others, the startup said in a statement on Thursday. In the seed funding round, which valued the healthcare venture at $243 million, PB Fintech invested $62 million for a 26% stake, while General Catalyst infused $50 million for 20.57%. Incorporated on 1 January 2025, Gurugram-based healthcare firm will use the proceeds to set up a 1,000-bed hospital network in the National Capital Region and accelerate product development and technological innovation. This is part of the startup's broader aim to build an end-to-end platform that integrates healthcare and insurance. To be clear, PB Healthcare is a separate entity from listed PB Fintech, which owns Policybazaar and Paisabazaar. Though Yashish Dahiya, chairman and group chief executive of PB Fintech, is leading the venture, PB Fintech's role will be that of an incubator and not a long-term owner. In 2024, Dahiya revealed his plans to enter the healthcare space through a one-time investment of up to $100 million for a 20-30% stake. He explained the new healthcare entity will eventually generate its own resources for growth and may attract investments from private equity firms and other financial institutions. 'Our vision is to create a truly integrated healthcare ecosystem where patients can experience frictionless, high-quality care. Our focus remains on building a tech-first healthcare platform that improves outcomes, enhances trust, and redefines the care journey for millions across India,' said Dahiya. The company will improve long-term health outcomes, reduce avoidable surgeries, and deliver a more predictable, full-stack patient experience by operating its own hospitals, leveraging technology, analytics, and a preventive-care approach, PB Healthcare said in the statement.


Business Upturn
24-04-2025
- Business
- Business Upturn
PB Fintech invests Rs 539 crore in PB Healthcare; stake to reduce to 32.14% after external funding round
By Aditya Bhagchandani Published on April 24, 2025, 19:19 IST PB Fintech Limited, the parent company of Policybazaar, has announced a ₹539.40 crore investment in its wholly-owned subsidiary PB Healthcare Services Private Limited, as part of the first tranche of a seed funding round. The funding aligns with the company's earlier shareholder approval of up to ₹696 crore, secured through a postal ballot on April 15, 2025. The seed round totals ₹1,461.60 crore, with participation from PB Fintech and external investors. As a result of the fresh capital infusion and the creation of an Employee Stock Option Plan (ESOP) pool, PB Fintech's stake in PB Healthcare will reduce from 100% to 32.14% on a fully diluted basis. PB Healthcare, incorporated on January 1, 2025, operates in the healthcare and allied services sector. The investment aims to strengthen the subsidiary's financial foundation and support future growth. The funding was executed through the allotment of 5,39,40,000 Compulsory Convertible Preference Shares (CCPS) at ₹100 per share. The transaction is classified as a related-party deal but was conducted at fair market value, as determined by a registered valuer. PB Fintech stated that the dilution is a strategic step to bring in long-term investors and build a robust team via ESOPs. Disclaimer: The information provided is for informational purposes only and should not be considered financial or investment advice. Stock market investments are subject to market risks. Always consult a financial advisor before making investment decisions. Aditya Bhagchandani serves as the Senior Editor and Writer at Business Upturn, where he leads coverage across the Business, Finance, Corporate, and Stock Market segments. With a keen eye for detail and a commitment to journalistic integrity, he not only contributes insightful articles but also oversees editorial direction for the reporting team.